RNF8 and melanoma: RNF8 affects DNA damage response by inducing G2/M checkpoint activation [10], and downregulation of the G2/M checkpoint gene was significantly associated with prolonging progression-free survival with immune checkpoint inhibitors therapy and aided in the treatment of melanoma [11].